Lukacs N W, Chensue S W, Strieter R M, Warmington K, Kunkel S L
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602.
J Immunol. 1994 Jun 15;152(12):5883-9.
Recent studies have demonstrated a crucial role for TNF during inflammatory granuloma formation. In addition, TNF has been shown to up-regulate adhesion molecules that participate in cellular recruitment and lymphocyte activation. In the present study, we have examined the mechanism of TNF activation during Schistosoma mansoni egg granuloma formation and its relationship to the expression of ICAM-1. Our initial studies showed that high affinity human soluble TNFR coupled to the Fc portion of an Ig (sTNFR:Fc construct) could effectively diminish granuloma formation and lymphocyte activation in vivo. We have also assessed the increased expression of ICAM-1, its contribution to granuloma development, and its relationship with TNF during lesion formation. Increased steady state ICAM-1 mRNA expression was observed in primary egg granulomas when compared with normal lung and foreign body (Sephadex bead) granulomas, which suggests a role for ICAM-1 in Ag-induced lesion formation. Subsequent studies have demonstrated that sTNFR:Fc treatment down-regulated granuloma formation and ICAM-1 expression, thus suggesting one mechanism of TNF involvement in granuloma formation was through the induction of ICAM-1. Anti-ICAM-1 decreased the soluble egg Ag-specific T cell proliferation in vitro. In addition, passive immunization of mice with anti-ICAM-1 mAb during primary granuloma formation resulted in an attenuation of lesion development as compared with lesion development in a control Ab-treated group. The proliferative response to soluble egg Ag was also significantly reduced in ex vivo experiments that used spleen cells from the anti-ICAM-1 treated mice. These data demonstrate that both TNF and ICAM-1 participate in lymphocyte activation and granuloma formation and suggest that one mechanism of TNF in granuloma development is through TNF-induced ICAM-1 expression.
近期研究已证实肿瘤坏死因子(TNF)在炎性肉芽肿形成过程中起关键作用。此外,TNF已被证明可上调参与细胞募集和淋巴细胞激活的黏附分子。在本研究中,我们探讨了曼氏血吸虫卵肉芽肿形成过程中TNF激活的机制及其与细胞间黏附分子-1(ICAM-1)表达的关系。我们最初的研究表明,与Ig的Fc部分偶联的高亲和力人可溶性TNFR(sTNFR:Fc构建体)可有效减少体内肉芽肿形成和淋巴细胞激活。我们还评估了ICAM-1表达的增加、其对肉芽肿发展的贡献以及在病变形成过程中它与TNF的关系。与正常肺组织和异物(葡聚糖凝胶珠)肉芽肿相比,在原发性卵肉芽肿中观察到ICAM-1 mRNA稳态表达增加,这表明ICAM-1在抗原诱导的病变形成中发挥作用。后续研究表明,sTNFR:Fc处理可下调肉芽肿形成和ICAM-1表达,因此提示TNF参与肉芽肿形成的一种机制是通过诱导ICAM-1。抗ICAM-1在体外可降低可溶性虫卵抗原特异性T细胞增殖。此外,在原发性肉芽肿形成过程中用抗ICAM-1单克隆抗体对小鼠进行被动免疫,与对照抗体处理组的病变发展相比,病变发展减弱。在使用抗ICAM-1处理小鼠的脾细胞进行的体外实验中,对可溶性虫卵抗原的增殖反应也显著降低。这些数据表明TNF和ICAM-1均参与淋巴细胞激活和肉芽肿形成,并提示TNF在肉芽肿发展中的一种机制是通过TNF诱导的ICAM-1表达。